HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete transitioning to the radial approach for primary percutaneous coronary intervention: a real-world single-center registry of 1808 consecutive patients with acute ST-elevation myocardial infarction.

AbstractOBJECTIVES:
To compare the short- and long-term outcomes of transradial approach (TRA) versus transfemoral approach (TFA) for primary percutaneous coronary intervention (PPCI) during a complete institutional transition from TFA to TRA.
METHODS AND RESULTS:
An all-comer population of ST-elevation myocardial infarction (STEMI) patients (n=1808) who underwent PPCI using TRA (n=1162) and TFA (n=646) from October 2007 to December 2010 were enrolled. TRA was used in 25% of PPCIs by 2007 and in 96% of PPCIs in 2010. Primary endpoints were cardiovascular death and major adverse cardiac event (MACE), defined as a composite of death, stroke, reinfarction, and target vessel revascularization at 30 days and 1 year. At 30 days, TRA compared to TFA was associated with a significant reduction of cardiovascular mortality (5.2% vs 10.5%; P<.001), significant MACE reduction (7.3% vs 12.5%; P<.001), fewer access-site complications (0.9% vs 8.2%; P<.001), and lower TIMI major bleeding (1.1% vs 4.3%; P<.001). At 1 year, the cardiovascular mortality and MACE rates were also in favor of the TRA group (6.9% vs 11.5%; P<.001 and 11.6% vs 20.1%; P<.001), respectively.
CONCLUSION:
Complete transition from femoral access to a preferred radial access is safe and effective for STEMI patients undergoing PPCI, with a favorable effect on short- and long-term outcomes.
AuthorsSasko Kedev, Oliver Kalpak, Surya Dharma, Slobodan Antov, Jorgo Kostov, Hristo Pejkov, Igor Spiroski
JournalThe Journal of invasive cardiology (J Invasive Cardiol) Vol. 26 Issue 9 Pg. 475-82 (Sep 2014) ISSN: 1557-2501 [Electronic] United States
PMID25198492 (Publication Type: Comparative Study, Journal Article, Observational Study)
Chemical References
  • Anticoagulants
  • Platelet Aggregation Inhibitors
Topics
  • Aged
  • Anticoagulants (therapeutic use)
  • Cohort Studies
  • Death, Sudden, Cardiac (epidemiology)
  • Electrocardiography
  • Female
  • Femoral Artery
  • Hemostasis, Surgical
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Myocardial Infarction (physiopathology, therapy)
  • Percutaneous Coronary Intervention (methods)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Radial Artery
  • Registries
  • Retrospective Studies
  • Stroke (epidemiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: